Yes! Take away the 3.6 million spent on R&D and
you have a company with no future. Fluffy, ATRX is
still spending money on TRYING to expand the market for
Atridox and if you want the few institutions that own
stock in ATRX to flee in a New York minute, just tell
them that ATRX isn't spending any money on R&D. Come
on man! Get real with your dreams.
I do not think that the R and D expenditures
contributed to today's debacle. It is my opinon, shared by
many others who considered it , I believe, that a
large part of the money was spent on trials of the
prostate therapy and the acne therapy. These therapies are
not highly experimental and should result in new
income producing products. No, I am afraid that our
latest heart breaker occurred because of wishful
thinking. All of the analysis and projections- made by
people for whom I have great regard - were flawed
because they were necessarily based on unverifable
assumptions,being based on such assumptions because management for
whatever the reason was tight lipped.
And so those who
survive should stanch the bleeding as best as they can,
bind their wounds , clinch their teeth, and look to
the next quarter which I believe , based on the small
hints from management, should be much better.
Why don't you get on the conference
call and lead off with you question/statement about
ATRX spending too much on R&D. If anything, you should
be pleased that ATRX has so many products in the
works. Please explain your business background that
leads you to believe that ATRX is spending too much on
R&D. If you think this is a major question, I would be
willing to wager that the analyst on the CC will want to
know more about their R&D program and NOT one of them
will think they are doing too much in this area.
I called her on monday she is investor relations
right? I asked her about a dozen questions, she as they
refer to in baseball went 0 for 12. When i talk to her
it's like talking to yourself you ask a question she
pauses says i don't know and then you summize an answer
yourself. I wish I had a job that simple answer phones say
i don't know or can't say and get off. We have
spent time,money(lots) waiting for this piece of crap
to do something and our company doesnt say anything
to help us out. Our UK approval that was suppose to
come at the end of march didn't and in april they
finally had the decency to let us know there were
problems. We have shit for a PR company and that is why
this stock is trading in the 9's. I hope we show no
mercy at 200est at the cc.
Actually when LGND recently got FDA approval on
TWO cancer drugs the stock has since declined over
50% from the announcement.
substainable revenue and profits are what the institutional
investors are looking for.